The TACL Steering & Prioritization Committee (SPC) is where all of TACL's projects begin. Investigators who are interested in conducting a study within TACL submit their ideas to the SPC in the form of a LOI (Letter of Intent) for review and input. The SPC uses their expertise to work with investigators to turn LOIs into protocols. Under the leadership of SPC Scientific Chair, Andrew Place, MD, PhD, at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, the SPC guides TACL and serves as the executive decision making authority over all administrative, regulatory and protocol related matters. The SPC meets on a monthly basis.
SPC Responsibilities